Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATHENA pilot trial of low-dose triple blood pressure pill for adults with minor neurocognitive disorder
ACTRN12621000121864Phase 3Terminated
- Sponsor
- The George Institute for Global Health
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of telmisartan, amlodipine and indapamide in hypertension (HTN) and Mild Cognitive Impairment (MCI), sponsored by The George Institute for Global Health. Primary endpoint: Feasibility at Week 6. Started Dec 2021; status: terminated.
02
Drugs
telmisartanamlodipineindapamide
03
Conditions
hypertension (HTN)Mild Cognitive Impairment (MCI)
Beyond the preview
Go deeper on ACTRN12621000121864.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12621000121864.